HAIER BIOMEDICAL(688139)2025-02-27 09:25Financial Performance - Total revenue for 2024 reached RMB 2,283.83 million, a slight increase of 0.13% compared to RMB 2,280.90 million in the previous year[3] - Operating profit decreased by 8.34% to RMB 401.83 million from RMB 438.40 million year-on-year[3] - Net profit attributable to shareholders of the parent company was RMB 366.63 million, down 9.71% from RMB 406.07 million in the previous year[3] - Basic earnings per share decreased by 9.38% to RMB 1.16 from RMB 1.28 year-on-year[3] Asset and Cash Flow - Total assets increased by 4.74% to RMB 5,787.47 million from RMB 5,525.68 million at the beginning of the period[4] - The company achieved a 17.01% year-on-year increase in net cash flow from operating activities, supporting long-term healthy development[7] Market Growth and Strategy - Fourth-quarter revenue growth accelerated to 10.40%, with all markets and sectors showing positive growth[5] - Non-storage new industries maintained a growth rate of over 20% throughout the year, driven by continuous product innovation[5] - The company aims to enhance overseas localization and AI-driven digital upgrades to return to normal growth trajectories[7] Financial Reporting - The financial data presented are preliminary and unaudited, with final figures to be disclosed in the annual report[9]